Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Lymphocyte function-associated antigen 3 (LFA3) variant polypeptides and methods of use thereof to treat CD2-mediated immune diseases, disorders or conditions

Lymphocyte function-associated antigen 3 (LFA3) variant polypeptides and methods of use thereof to treat CD2-mediated immune diseases, disorders or conditions

US Patent 12103958 · Granted Oct 1, 2024

Estimated economic value: $338,444,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Preservation of pancreatic islet grafts in the extrahepatic space2025
CD127 expression inversely correlates with FoxP3 and suppressive function of CD42025
CAR-t cells and autoimmune diseases2025
Preservation of pancreatic islet grafts in the extrahepatic space2024
Preservation of pancreatic islet grafts in the extrahepatic space2024
BTLA fusion protein agonists and uses thereof2024
Non-fibrous porous film and method for tissue adhesion2022
Anti-IL-2 antibodies and compositions and uses thereof2022
Anti-IL-2 antibodies and compositions and uses thereof2022
Anti-IL-2 antibodies and compositions and uses thereof2022
Anti-IL-2 antibodies and compositions and uses thereof2022
Non-volatile memory (NVM) based method for performance acceleration of container2022